A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site (Q41107404)
Jump to navigation
Jump to search
scientific article published on October 1, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site |
scientific article published on October 1, 1992 |
Statements
1 reference
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site (English)
D. Kelsen
D. S. Martin
J. Colofiore
R. Sawyer
1 October 1992
1 reference
1 reference
70
1 reference
7
1 reference
1988-1992
1 reference
Identifiers
1 reference
1 reference